CIK 0001582554
- Non-accelerated filer
- Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463011414
- Phone
- +1 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Other acquisition Director acquired 3,600 shares (other)
- 4 Other acquisition Director acquired 25,500 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 2,639,039 shares (gift)
- 4 Open-market buy Director bought 100,000 shares at $0.73 ($73,050)
- 4 Gift Director gave 2,639,039 shares (gift)
- 4 Exercise or conversion Director acquired 278,407 shares (option exercise)
- 4 Grant or award Director acquired 26,450 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $0.65 ($6,500)
- 4 Open-market buy President and CEO bought 10,000 shares at $0.65 ($6,500)
- 4 Grant or award Director acquired 8,260 shares (grant or award)
- 4 Other acquisition Chief Scientific Officer acquired 2,000 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,573 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 12 · 232 filings